Tempus launches new algorithm to close care gaps in guideline-directed IHC testing
Tempus AI, a leader in Artificial Intelligence and precision medicine, has announced the launch of a new program specifically geared towards using algorithms to surface patients who are more likely to test positive for actionable biomarkers, and who should...